Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Healthcare Cannabis
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Aurora Cannabis Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by fortune420on Sep 29, 2018 6:03am
227 Views
Post# 28713947

Canopy tries to trademark Chronic By Dre without permission

Canopy tries to trademark Chronic By Dre without permission

Canada-based Canopy Growth Corp. has withdrawn a trademark it filed in August for the phrase “Chronic By Dre,” according to a company spokesman.
“Chronic By Dre” refers to the 1992 album by rapper and music mogul Andre Young, also known as Dr. Dre. It also works as a hat-tip to “CBD” or cannabidiol, a non-psychoactive substance found in marijuana and hemp plants.
In a statement, Canopy CGC, -1.58% WEED, -7.23%  vice president of communications and media Jordan Sinclair said that the trademark was filed in error and the company does not have a relationship with Young, or “rights to Mr. Young’s name, likeness or any of his intellectual property.” Sinclair said that the company apologizes to Dr. Dre.

https://www.marketwatch.com/story/canopy-withdraws-chronic-by-dre-trademark-it-filed-without-dr-dres-permission-2018-09-28?siteid=yhoof2&yptr=yahoo

Link to Government of Canada trademark applications:

https://www.ic.gc.ca/app/opic-cipo/trdmrks/srch/viewTrademark?id=1917759&lang=eng
 



 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities